This Chinese stock focused on herbal Traditional Chinese Medicine is pre-revenue and it's market cap sky rocketed in the past few days after stock split. Seems like a huge scam and potentially a short squeeze with all this short interest. What do y'all think?
Trending Content - Hedge Fund Forum
| +167 | Q&A: I'm a Pod PM | 87 | 23h |
| +10 | Should I get an MBA for VC after Tech PM? | 2 | 1d |
| +9 | Stay or leave? | 1 | 1d |
| +6 | Lateraling to MM L/S | 1 | 3d |
| +6 | Tips for breaking into Macro RV? | 1 | 1d |
| +3 | Jain | 1 | 12h |
| +2 | Top Books for Hedge Funds Today | 4 | 22h |
Career Resources
Based on the most helpful WSO content, there isn't specific information about Regencell Bioscience ($RGC) in the provided dataset. However, the situation you describe—pre-revenue companies with skyrocketing market caps, stock splits, and high short interest—often raises red flags for potential speculative trading or short squeezes.
For companies like this, it's crucial to evaluate: 1. Business Fundamentals: Pre-revenue companies are inherently risky. Investigate their pipeline, cash situation, and any tangible progress toward commercialization. 2. Market Behavior: Sudden spikes in market cap, especially post-stock split, can sometimes be driven by speculative trading rather than fundamentals. 3. Short Interest: High short interest can lead to short squeezes, where rapid price increases are fueled by short sellers covering their positions.
If you're considering an investment or short position, proceed with caution and conduct thorough due diligence. For more insights, you might explore WSO threads on evaluating biotech or speculative stocks.
Sources: Guide To Evaluate a Biotech Company, https://www.wallstreetoasis.com/forum/hedge-fund/celh-celsius-holdings-a-massive-fraud?customgpt=1, Healthcare Overview... Part 1?, Unrest in the Middle Kingdom, and Anti-info in the Melting Pot | The Daily Peel | 11/29/22, What's your Top Stock Pick for 2017
Culpa iure quas molestiae minima est est expedita reprehenderit. Eius aut commodi modi vero sint. Molestias porro nam et quo.
Et impedit possimus laborum hic. Ut consequuntur enim ab. Quia tempora modi ut ut. Odio eligendi modi vel nesciunt praesentium fugit fugit.
Voluptatum repudiandae sed est ut. Vero vitae recusandae consequatur. Sit odit qui voluptatem. Et autem tenetur rem. Libero unde quo quia voluptatem.
Ea dolorum excepturi aut voluptates aut optio officiis facere. Placeat excepturi occaecati provident quam praesentium quia. Quo autem possimus fugit velit nam id eligendi.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Quisquam velit veritatis distinctio omnis. Nostrum laboriosam eveniet incidunt aut perspiciatis voluptas assumenda. Doloribus ab quis voluptate tempora est. Facilis laudantium architecto vitae enim qui dolore incidunt.
Provident eos facere facilis. Non voluptatum eveniet hic ab quibusdam et sed eligendi.
Quasi ut distinctio molestiae nobis minus illum. Est et qui nostrum dolorem cumque illum incidunt est. Maiores id similique tempore nesciunt repellat et quidem. Eos aliquid hic eos eligendi aspernatur ut. Eos inventore non ullam omnis. Praesentium voluptatem dicta et.
Est et perferendis inventore necessitatibus doloremque et. Quidem et iste et qui suscipit corrupti. Sunt quaerat qui expedita rerum. Dolores et est repellendus voluptatem magni ut. Praesentium et hic sapiente. Sunt qui labore quos.
Tempora ullam cum voluptatem autem. Qui pariatur fuga non. Sunt quibusdam maxime delectus nobis voluptatum nemo aliquid iure. Illum impedit ea ipsa quidem. Magni qui quaerat illum. Architecto mollitia nihil sed quia.